BIOMAT Database Logo BIOMAT Database Logo

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. 2000

G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, NY 10010, USA.

Natural killer T (NKT) cells are a unique population of lymphocytes that coexpress a semiinvariant T cell and natural killer cell receptors, which are particularly abundant in the liver. To investigate the possible effect of these cells on the development of the liver stages of malaria parasites, a glycolipid, alpha-galactosylceramide (alpha-GalCer), known to selectively activate Valpha14 NKT cells in the context of CD1d molecules, was administered to sporozoite-inoculated mice. The administration of alpha-GalCer resulted in rapid, strong antimalaria activity, inhibiting the development of the intrahepatocytic stages of the rodent malaria parasites Plasmodium yoelii and Plasmodium berghei. The antimalaria activity mediated by alpha-GalCer is stage-specific, since the course of blood-stage-induced infection was not inhibited by administration of this glycolipid. Furthermore, it was determined that IFN-gamma is essential for the antimalaria activity mediated by the glycolipid. Taken together, our results provide the clear evidence that NKT cells can mediate protection against an intracellular microbial infection.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010962 Plasmodium berghei A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni. Plasmodium bergheus,berghei, Plasmodium
D010967 Plasmodium yoelii A species of PLASMODIUM causing malaria in rodents. Plasmodium yoelius,yoelius, Plasmodium
D005699 Galactosylceramides Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy. Galactocerebrosides,Galactosyl Ceramide,Galactosyl Ceramides,Galactosylceramide,Ceramide, Galactosyl,Ceramides, Galactosyl

Related Publications

G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.
December 2003, The Journal of experimental medicine,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.
July 2000, Gastroenterology,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases.
March 2007, Allergology international : official journal of the Japanese Society of Allergology,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.
March 2002, The Journal of experimental medicine,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
[Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
June 2005, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
February 2000, Immunology,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
α-galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice.
February 2019, Journal of cellular and molecular medicine,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infection.
June 2005, The Journal of urology,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
Localization of lymphocyte apoptosis in murine lymphoid tissues after stimulation of natural killer T cells with alpha-galactosylceramide.
December 2003, Archives of histology and cytology,
G Gonzalez-Aseguinolaza, and C de Oliveira, and M Tomaska, and S Hong, and O Bruna-Romero, and T Nakayama, and M Taniguchi, and A Bendelac, and L Van Kaer, and Y Koezuka, and M Tsuji
alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.
July 2005, American journal of respiratory cell and molecular biology,
Copied contents to your clipboard!